Laura E. Niklason - May 25, 2023 Form 4 Insider Report for Humacyte, Inc. (HUMA)

Signature
/s/ Laura E. Niklason by Dale A. Sander as Attorney-in-Fact
Stock symbol
HUMA
Transactions as of
May 25, 2023
Transactions value $
-$7,218,750
Form type
4
Date filed
5/26/2023, 05:05 PM
Previous filing
Mar 2, 2023
Next filing
Jun 15, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HUMA Common Stock Sale -$7.22M -2.63M -14.59% $2.75 15.4M May 25, 2023 By Ayabudge LLC F1
holding HUMA Common Stock 1.27M May 25, 2023 Direct
holding HUMA Common Stock 510K May 25, 2023 By spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales were made by Ayabudge LLC, an entity controlled by Brady W. Dougan. The transactions enabled Mr. Dougan to pay down leverage while providing a mechanism for the institutional healthcare investor purchasers to acquire shares of the Issuer at a time that the Issuer was not conducting a financing transaction and was not making any additional shares available for purchase. Dr. Niklason is treated as indirectly beneficially owning the shares sold, resulting in the requirement to file this Form 4. However, no shares directly owned by Dr. Niklason were sold in these transactions.